Evaluation of Autologous Engineered Skin Substitute (ESS-W) Compared to Meshed, Split-Thickness Autograft (AG) for Treatment of Deep Partial- and Full-Thickness Thermal Burn Wounds in Adult Patients
Not yet recruiting
Phase of Trial: Phase II
Latest Information Update: 15 Sep 2016
At a glance
- Drugs Human skin replacement Amarantus Bioscience (Primary)
- Indications Burns
- Focus Adverse reactions; Therapeutic Use
- Sponsors Amarantus Bioscience Holdings
- 29 Aug 2016 Planned initiation date changed from 1 Apr 2016 to 1 Sep 2016.
- 23 Feb 2016 Planned initiation date changed from 1 Dec 2015 to 1 Apr 2016 as reported by ClinicalTrials.gov.
- 19 Oct 2015 Planned End Date changed from 1 Dec 2019 to 1 Jul 2020 as reported by ClinicalTrials.gov record.